1a) Welcome to a two-part (today and Monday) live-tweeted, #accredited #tweetorial on 2⃣ 🔑#LBCTs from @ACCinTouch #ACC23 in #NewOrleans 🥳on advances in #hyperlipidemia management #LLT. Our expert presenter and commentator is none other than @CMichaelGibson....
2a) This is the next instalment of @cardiomet_CE‘s 10-part foundational series on #lipid_management! It is accredited for #CME/CE and intended for #physicians #physicianassociates #nurses #nursepractitioners #pharmacists. #FOAMed @MedTweetorials #cardiotwitter—...
2a) This is the next instalment of @cardiomet_CE’s 10-part #tweetorial foundational series on #lipid management! It is accredited for #CME/CE and intended for #physicians #physicianassociates #nurses #nursepractitioners #pharmacists.#FOAMed @MedTweetorials...
1b) The new #gduidelines can be found at 🔓 https://t.co/06ldtc4m2A along with an infographic 🔓https://t.co/4JwRfqXEEw— cardio-met (@cardiomet_CE) July 19, 2022 3) There continues to be 🙅♂️ debate that #LDL_C is a primary cause of #CVD, the leading cause of death...
1) Welcome to an #accredited #tweetorial on aggressive treatment of elevated #LDL-C in the post-MI and/or #diabetic patient to improve #ASCVD outcomes. Our returning @cardiomet_CE expert author is cardiologist Christopher Cannon MD @cpcannon of @harvardmed &...
2) This #tweetorial, accredited for #CME/CE and intended for #physicians #physicianassociates #nurses #nursepractitioners #pharmacists is supported by an educational grant from Esperion Therapeutics. See faculty disclosures at https://t.co/gvXca4G9Xm.—...